Apr 1, 2024, 13:09
Yüksel Ürün: This research suggests ctDNA could revolutionize pre-surgical decision-making and treatment strategies, ensuring more personalized care
Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X/Twitter:
“Circulating tumor DNA (ctDNA) testing before radical cystectomy can predict disease recurrence and advanced pathology in Bladder Cancer patients.
This research suggests ctDNA could revolutionize pre-surgical decision-making and treatment strategies, ensuring more personalized care.”
View additional information.
Source: Yüksel Ürün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 05:54
Dec 21, 2024, 05:42
Dec 21, 2024, 04:55
Dec 21, 2024, 03:42
Dec 21, 2024, 03:31